| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/17/2003 | US20030134867 Preventing extracellular release |
| 07/17/2003 | US20030134148 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers |
| 07/17/2003 | CA2472580A1 Broad spectrum inhibitors |
| 07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
| 07/16/2003 | EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326632A2 Agents for the treatment of viral infections |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1224182B1 N-substituted 1-(butyrolactone)-isoquinolines for treating nervous disorders |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430514A Use of galantamine for treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 07/16/2003 | CN1429611A Greater celandine extract and its preparation method and application |
| 07/16/2003 | CN1429548A Medicine for treating disease related to low cyclo GMP level |
| 07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 07/15/2003 | US6593350 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse |
| 07/15/2003 | US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases |
| 07/15/2003 | US6593334 Camptothecin-taxoid conjugates as antimitotic and antitumor agents |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/10/2003 | WO2003055889A1 Process for preparing a heteroaromatic compound substituted with one or more ether groups |
| 07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003041653A3 Cytotoxic agents |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | US20030130305 Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease |
| 07/10/2003 | US20030130297 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130270 Heterocyclic derivatives and their use as antithrombotic agents |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1325909A1 Tricyclic indole compounds having affinity for serotonin receptor |
| 07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 07/09/2003 | CN1429229A Hydroxylamine esters as polymerization initiators |
| 07/09/2003 | CN1428343A Technological process for producing camptothecine and 10-hydroxycamptothecine |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/08/2003 | US6589968 Epothilone compounds and methods for making and using the same |
| 07/08/2003 | US6589962 Certain alpha -hydroxy- gamma -(((carbocyclic- or heterocyclic- substituted)amino)carbonyl)alkanamide derivatives are described as inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in |
| 07/08/2003 | US6589939 Camptothecin derivatives having antitumor activity |
| 07/08/2003 | US6589934 Methods of treatment of non insulin dependent diabetes mellitus, antagonists of the delayed rectifier potassium channel Kv2.1, methods of using and preparing the antagonists and assays for identifying such antagonist |
| 07/08/2003 | CA2151096C New 1,4-oxazine tetracyclic derivatives; process for preparing them and pharmaceutical copossitions containing them |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | WO2003053946A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053561A2 A surfactant assisted nanomaterial generation process |
| 07/03/2003 | WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 07/03/2003 | US20030125369 New indenoindolone compounds |
| 07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
| 07/03/2003 | US20030125327 Prodrugs of imidazopyridine derivatives |
| 07/03/2003 | CA2471355A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | CA2469884A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/02/2003 | EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
| 07/02/2003 | EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 07/02/2003 | EP1323420A1 Remedies for inflammatory bowel diseases |
| 07/02/2003 | EP1323419A1 Airway mucus secretion inhibitors |
| 07/02/2003 | EP1323160A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 07/02/2003 | EP1322906A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 07/02/2003 | EP1322651A1 Bicyclic heteroaromatic compounds |
| 07/02/2003 | EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa |
| 07/02/2003 | EP1322619A1 Isoquinolinone potassium channel inhibitors |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322615A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 07/02/2003 | EP1322611A1 Chemical compounds |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP0990647B1 Process for producing quinolone derivatives |
| 07/02/2003 | CN1113057C Quinoline derivatives |
| 07/02/2003 | CN1112848C Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component |
| 07/01/2003 | US6586604 Tricyclic amine derivatives |
| 07/01/2003 | US6586452 C1 to C4 side chain modified nodulisporic acid analogs |
| 07/01/2003 | US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders |
| 07/01/2003 | US6586414 Treatment of cerebrovascular disease |
| 06/26/2003 | WO2003051884A1 Fused indole compound, process for producing the same, and use |
| 06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 06/26/2003 | WO2003051868A1 Lactams as tachykinin antagonists |
| 06/26/2003 | WO2003051844A1 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 06/26/2003 | WO2003051303A2 The total synthesis of merrilactone a |
| 06/26/2003 | WO2003051289A2 Solubilized topoisomerase poison agents |
| 06/26/2003 | WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 06/26/2003 | US20030120074 Cardioprotective phosphonates and malonates |
| 06/26/2003 | US20030120066 Synthetic peptides |
| 06/26/2003 | US20030119887 Lactacystin analogs |
| 06/26/2003 | US20030119868 Gyrase inhibitors and uses thereof |
| 06/26/2003 | US20030119833 Treating cardiovascular diseases |
| 06/26/2003 | CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives |
| 06/26/2003 | CA2470236A1 Lactams as tachykinin antagonists |
| 06/26/2003 | CA2470009A1 The total synthesis of merrilactone a |
| 06/26/2003 | CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof |
| 06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | CA2467279A1 Solubilized topoisomerase poison agents |
| 06/25/2003 | EP1320611A2 Heterologous production of polyketides |
| 06/25/2003 | EP1320571A1 3-spiro-cyanin fluorochromes and their use in bioassays |
| 06/25/2003 | EP1320369A1 A method of analgesia |